皮肌炎与多发性肌炎持续存在的过早死亡差距:英国一般人群队列研究
基于英国健康改善网络(THIN)的队列研究,纳入410例皮肌炎(DM)和407例多发性肌炎(PM)患者,按诊断年份分为早期(1999-2006)和晚期(2007-2014)队列。两队列DM患者死亡率均显著高于匹配对照,晚期队列多变量HR为5.42(95%CI 3.11-9.45),较早期队列的7.51(95%CI 4.20-13.42)无显著交互作用(P=0.59)。PM呈现类似趋势。结论认为DM/PM的过早死亡差距近年未显著改善。
要点
- DM/PM患者死亡率显著高于一般人群,晚期队列HR仍达5.42。
- 早期与晚期队列的死亡率HR无显著差异(交互P=0.59)。
- PM患者呈现与DM相似的持续超额死亡趋势。
核心结论
- DM/PM患者的过早死亡差距在近年未显著改善,提示治疗需求未满足。
研究设计与样本
- 基于英国健康改善网络(THIN)的一般人群匹配队列研究,纳入410例DM和407例PM患者,按诊断年份分早期(1999-2006)和晚期(2007-2014)队列,每例匹配至多10名对照。
主要发现
- 早期DM队列死亡率为71.5/1000人年,对照为12.9/1000人年;晚期DM队列死亡率为49.1/1000人年,对照为10.4/1000人年。
- DM多变量HR早期为7.51(95%CI 4.20-13.42),晚期为5.42(95%CI 3.11-9.45),交互P=0.59。
- DM多变量率差早期为56.2(95%CI 31.8-81.2)/1000人年,晚期为36.3(95%CI 19.6-53.0)/1000人年,交互P=0.15。
- PM患者呈现与DM相似的超额死亡趋势。
临床怎么用
- 提示临床需持续关注DM/PM患者的死亡风险,尽管年代推移但超额死亡差距未显著缩小。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: DM and PM are associated with substantial morbidity and mortality. We aimed to examine recent trends. METHODS: Using The Health Improvement Network, we identified patients with incident DM/PM (defined by ≥1 Read diagnosis code) aged 18-89 years with ≥1 year of continuous enrolment prior to the cohort entry date and up to 10 comparators matched on age, sex and entry year. The cohort was divided in two based on the year of DM/PM diagnosis: the early cohort (1999-2006) and late cohort (2007-2014). We calculated multivariable hazard ratios (HR) for death using a Cox-proportional hazards model and multivariable rate differences (RD) using an additive hazard model. RESULTS: We identified 410 DM cases (mean age: 58 years, 66% female) and 407 PM cases (mean age: 59 years, 61% female). Both DM cohorts had excess mortality compared with the comparison cohorts (71.5 vs 12.9 deaths/1000 person-years [PY] in the early cohort and 49.1 vs 10.4 deaths/1000 PY in the late cohort). The multivariable HRs were 7.51 (95% CI: 4.20, 13.42) in the early cohort and 5.42 (95% CI: 3.11, 9.45) in the late cohort (P-value for interaction = 0.59), and multivariable RDs were 56.2 (95% CI: 31.8, 81.2) in the early cohort and 36.3 (95% CI: 19.6, 53.0) in the late cohort (P-value for interaction = 0.15). A similar trend existed in PM. CONCLUSION: The premature mortality gap in DM/PM has not considerably improved in recent years, highlighting an unmet need for therapeutic improvement.
引用
- D'Silva KM, Li L, Lu N, et al. Persistent premature mortality gap in dermatomyositis and polymyositis: a United Kingdom general population-based cohort study. Rheumatology (Oxford). 2021. PMID: 33175975. doi:10.1093/rheumatology/keaa661
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。